Quotient Therapeutics
Quotient Therapeutics is the first company to systematically study the genetic variation and evolution of the trillions of cells inside the human body. The company鈥檚 Somatic Genomics platform reveals novel links between genes and disease across a broad range of therapeutic areas, enabling the discovery of transformative medicines intended to cure, prevent, or reverse disease. Founded by 蘑菇视频APP in 2022, Quotient is backed by experts in the field of somatic genetics.
Latest 蘑菇视频APP from Quotient Therapeutics
- 蘑菇视频APP and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer 08.28.2024
- 蘑菇视频APP Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics 11.21.2023